Moleculin Biotech SG&A Expense (Quarterly) Analysis

Moleculin Biotech Inc (MBRX)

5.08 +0.05 (+0.99%) USD | NASDAQ | May 17, 16:00

5.08 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
March 31, 2024	2.393M
December 31, 2023	2.252M
September 30, 2023	2.635M
June 30, 2023	2.492M
March 31, 2023	2.637M
December 31, 2022	2.838M
September 30, 2022	3.087M
June 30, 2022	3.196M
March 31, 2022	2.422M
December 31, 2021	1.992M
September 30, 2021	2.021M
June 30, 2021	2.434M
March 31, 2021	1.939M
December 31, 2020	1.663M
September 30, 2020	1.659M
June 30, 2020	1.653M
March 31, 2020	1.81M

Date	Value
December 31, 2019	1.564M
September 30, 2019	1.672M
June 30, 2019	1.484M
March 31, 2019	1.591M
December 31, 2018	1.37M
September 30, 2018	1.248M
June 30, 2018	1.22M
March 31, 2018	1.392M
December 31, 2017	1.103M
September 30, 2017	1.338M
June 30, 2017	0.80M
March 31, 2017	0.848M
December 31, 2016	0.533M
September 30, 2016	0.924M
June 30, 2016	0.618M
March 31, 2016	0.306M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.484M

Minimum

Jun 2019

3.196M

Maximum

Jun 2022

2.192M

Average

2.136M

Median

SG&A Expense (Quarterly) Benchmarks